Stay updated on NT-814 Efficacy in Menopausal Symptoms Clinical Trial
Sign up to get notified when there's something new on the NT-814 Efficacy in Menopausal Symptoms Clinical Trial page.

Latest updates to the NT-814 Efficacy in Menopausal Symptoms Clinical Trial page
- ChecktodayChange DetectedMinor version update: v3.4.0 replaced by v3.4.1; no changes to study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check10 days agoChange DetectedAdded a glossary display, a new 'Last Update Submitted that Met QC Criteria' label, a 'No FEAR Act Data' note, and a 'Revision: v3.4.0' tag; removed the older 'Last Update Submitted that met QC Criteria', 'No FEAR Act data' wording, and the previous 'Revision: v3.3.4' tag.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedNew Revision: v3.3.4 appears on the page, while the prior Revision: v3.3.3 entry is removed. This represents a minor backend/version update with no impact on the study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check45 days agoChange DetectedThe locations are now listed under a new top-level 'Locations' section with consolidated country/region entries, replacing the previous separate state-specific headings; the HHS Vulnerability Disclosure link is removed and the page revision is updated to v3.3.3.SummaryDifference0.9%

- Check74 days agoChange DetectedRevision tag updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check81 days agoChange DetectedThe government funding lapse notice was removed from the page. All other study details, locations, and planned outcomes remain the same.SummaryDifference0.3%

Stay in the know with updates to NT-814 Efficacy in Menopausal Symptoms Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NT-814 Efficacy in Menopausal Symptoms Clinical Trial page.